Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Sustained-Released Eye Treatment Company Raises $11.9M

Red-blue-green eye

A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round. . . . → Read More: Sustained-Released Eye Treatment Company Raises $11.9M

Trial Shows Insulin Capsules Reduce Blood Glucose Levels

Capsules in bubble package

Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes. . . . → Read More: Trial Shows Insulin Capsules Reduce Blood Glucose Levels

DNA Storage Start-Up Gains €5M in Seed Funds

DNAmolecule model

A new company developing DNA as a data storage medium with sustainable processes is raising €5 million ($US 5.22 million) in seed funding. . . . → Read More: DNA Storage Start-Up Gains €5M in Seed Funds

FDA Clears Digital Health Monitoring System

EmbracePlus device

A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use. . . . → Read More: FDA Clears Digital Health Monitoring System

Biomarker-Guided Depression Drug Trial Underway

Sad, depressed

The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein. . . . → Read More: Biomarker-Guided Depression Drug Trial Underway

Grant Funds Implanted Brain-Computer Spinal Injury Device

Motorized wheelchair

A project to develop a brain-computer device to stimulate upper and lower limb movement in people with spinal cord injuries is receiving a €3.7 million award. . . . → Read More: Grant Funds Implanted Brain-Computer Spinal Injury Device

Biotech, Regeneron in $2B Cancer Antibody Deal

Cancer magnified

A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal

Residual Cancer Detection Company Launches, Raises $56M

Blood vials

A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds. . . . → Read More: Residual Cancer Detection Company Launches, Raises $56M

Company to Boost Orphan Drugs in Europe

Europe at night from space

A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe

Biotech, M.D. Anderson Partner on Precision Drug Design

Network pointer

A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines. . . . → Read More: Biotech, M.D. Anderson Partner on Precision Drug Design